Unknown

Dataset Information

0

Identification of a novel PEX14 mutation in Zellweger syndrome.

ABSTRACT: Here we report a patient with Zellweger syndrome, who presented at the age of 3 months with icterus, dystrophy, axial hypotonia, and hepatomegaly. Abnormal findings of metabolic screening tests included hyperbilirubinaemia, hypoketotic dicarboxylic aciduria, increased C(26:0) and decreased C(22:0) plasma levels, and strongly reduced plasmalogen concentrations. In fibroblasts, both peroxisomal ?- and ?-oxidation were impaired. Liver histology revealed bile duct paucity, cholestasis, arterial hyperplasia, very small branches of the vena portae, and parenchymatic destruction. Immunocytochemical analysis of cultured fibroblasts demonstrated that the cells contain peroxisomal remnants lacking apparent matrix protein content and PEX14, a central membrane component of the peroxisomal matrix protein import machinery. Transfection of fibroblasts with a plasmid coding for wild-type PEX14 restored peroxisomal matrix protein import. Mutational analysis of this gene revealed a genomic deletion leading to the deletion of exon 3 from the coding DNA (c.85-?_170+?del) and a concomitant change of the reading frame (p.[Ile29_Lys56del;Gly57GlyfsX2]).

SUBMITTER: Huybrechts SJ 

PROVIDER: S-EPMC3027610 | biostudies-literature | 2009

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Here we report a patient with Zellweger syndrome, who presented at the age of 3 months with icterus, dystrophy, axial hypotonia, and hepatomegaly. Abnormal findings of metabolic screening tests included hyperbilirubinaemia, hypoketotic dicarboxylic aciduria, increased C(26:0) and decreased C(22:0) plasma levels, and strongly reduced plasmalogen concentrations. In fibroblasts, both peroxisomal α- and β-oxidation were impaired. Liver histology revealed bile duct paucity, cholestasis, arterial hype  ...[more]

Similar Datasets

Unknown Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders.
| S-EPMC2649967 | biostudies-literature
Unknown Identification of a novel mutation in PEX10 in a patient with attenuated Zellweger spectrum disorder: a case report.
| S-EPMC5547663 | biostudies-other
Unknown A novel <i>PEX1</i> mutation in a Moroccan family with Zellweger spectrum disorders.
| S-EPMC5390255 | biostudies-literature
Unknown Zellweger syndrome and associated phenotypes.
| S-EPMC1050768 | biostudies-other
Unknown Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D.
| S-EPMC1377633 | biostudies-other
Unknown Identification of a novel MYO7A mutation in Usher syndrome type 1.
| S-EPMC5788640 | biostudies-literature
Unknown Insufficiency of ciliary cholesterol in hereditary Zellweger syndrome.
| S-EPMC7298307 | biostudies-literature
Unknown Clinical aspects of Hyaline Fibromatosis Syndrome and identification of a novel mutation.
| S-EPMC7284039 | biostudies-literature
Unknown UGT1A1 gene mutation due to Crigler-Najjar syndrome in Iranian patients: identification of a novel mutation.
| S-EPMC3826477 | biostudies-literature
Unknown Identification and expression analysis of a novel intragenic EFNB1 mutation causing craniofrontonasal syndrome.
| S-EPMC4287793 | biostudies-literature